Evidence map›Paper›PMID 31504995›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2019

Chronic Hexavalent Chromium Exposure Induces Cancer Stem Cell-Like Property and Tumorigenesis by Increasing c-Myc Expression.

Zhishan Wang, Hsuan-Pei Lin, Yunfei Li, Hua Tao, Ping Yang, Jie Xie, Drew Maddy, Kazuya Kondo, Chengfeng Yang

Open access · greenAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Epigenetic downregulation of OEnvironmental pollution (Barking, Essex : 1987) · 2024
    Article
  8. Up-regulation of RNA mToxicology and applied pharmacology · 2023
    Article
  9. Review
  10. Article
  11. Epigenetic and epitranscriptomic mechanisms of chromium carcinogenesis.Advances in pharmacology (San Diego, Calif.) · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Zhishan WangDepartment of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, Kentucky 40536.
Hsuan-Pei LinDepartment of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, Kentucky 40536.
Yunfei LiDepartment of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, Kentucky 40536.
Hua TaoDepartment of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, Kentucky 40536.
Ping YangDepartment of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, Kentucky 40536.
Jie XieDepartment of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, Kentucky 40536.
Drew MaddyDepartment of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, Kentucky 40536.
Kazuya KondoDepartment of Oncological Medical Services, Graduate School of Biomedical Sciences, Tokushima University Graduate School, Tokushima City 770-8509, Japan.
Chengfeng YangDepartment of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, Kentucky 40536.
University of Kentucky · USGuangzhou Medical University · CNTokushima University · JP

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI KATHLEEN L. O'CONNOR · 2013 to 2026
$38.3M
Pilot Project ProgramP30ES026529 · NIEHS · UNIVERSITY OF KENTUCKY · PI John Anthony Bauer · 2017 to 2026
$15.4M
MECHANISM OF HEXAVALENT CHROMIUM CARCINOGENESIS ROLE OF LONG NON-CODING RNA DYSREGULATIONR01ES029942 · NIEHS · UNIVERSITY OF KENTUCKY · PI YANG, CHENGFENG · 2019 to 2023
$1.8M
EPIGENETIC MECHANISM OF THE SYNERGISTIC TUMORIGENIC EFFECT OF ARSENICAND BENZO[A]PYRENE CO-EXPOSURER01ES028256 · NIEHS · UNIVERSITY OF KENTUCKY · PI WANG, ZHISHAN · 2018 to 2022
$1.8M
THE EPIGENETIC MECHANISM OF HEXAVALENT CHROMIUM CARCINOGENESISR01ES026151 · NIEHS · UNIVERSITY OF KENTUCKY · PI YANG, CHENGFENG · 2016 to 2020
$1.7M
MGMT DOWN-REGULATION IN THE CARCINOGENICITY OF HEXAVALENT CHROMIUMR01ES029496 · NIEHS · UNIVERSITY OF KENTUCKY · PI WANG, ZHISHAN · 2019 to 2023
$1.7M
NCI NIH HHS P30 CA177558NIEHS NIH HHS P30 ES026529NIEHS NIH HHS R01 ES026151NIEHS NIH HHS R01 ES028256NIEHS NIH HHS R01 ES029496NIEHS NIH HHS R01 ES029942
6 · The paper itself

Abstract

Hexavalent chromium [Cr(VI)] is one of the most common environmental carcinogen causing lung cancer in humans; however, the mechanism of Cr(VI) carcinogenesis remains elusive. Cancer stem cells (CSCs) are considered as cancer initiating and maintaining cells. Ours and other recent studies showed that chronic Cr(VI) exposure induces CSC-like property representing an important mechanism of Cr(VI) carcinogenesis. However, how Cr(VI) exposure induces CSC-like property remains largely unknown. In this study, we found that stably knocking down the expression of c-Myc, a proto-oncogene and one of key stemness factors playing critical roles in cancer initiation and progression, in Cr(VI)-transformed human bronchial epithelial cells [BEAS-2B-Cr(VI)] significantly decreased their CSC-like property and tumorigenicity in mice. Moreover, stably knocking down c-Myc expression in parental nontransformed BEAS-2B cells significantly impaired the capability of chronic Cr(VI) exposure to induce CSC-like property and cell transformation. It was also found that stably overexpressing c-Myc alone in parental nontransformed BEAS-2B cells is capable of causing CSC-like property and cell transformation. Mechanistic studies showed that chronic Cr(VI) exposure increases c-Myc expression by down-regulating the level of microRNA-494 (miR-494). It was further determined that overexpressing miR-494 significantly reduces Cr(VI)-induced CSC-like property, cell transformation, and tumorigenesis mainly through down-regulating c-Myc expression. Together, these findings indicate that chronic low dose Cr(VI) exposure induces CSC-like property and tumorigenesis by increasing c-Myc expression through down-regulating the level of miR-494, revealing an important role of the proto-oncogene c-Myc in Cr(VI) carcinogenesis.

Indexed as

AnimalsBronchiCarcinogenesisCarcinogens, EnvironmentalCell LineCell Transformation, NeoplasticChromiumEpithelial CellsGene Knockdown TechniquesHumansMice, NudeMicroRNAsNeoplastic Stem CellsProto-Oncogene MasProto-Oncogene Proteins c-mycUp-RegulationCarcinogens, EnvironmentalChromiumchromium hexavalent ionMAS1 protein, humanMicroRNAsMIRN494 microRNA, humanMYC protein, humanProto-Oncogene MasProto-Oncogene Proteins c-myccancer stem cell-like propertycarcinogenesiscell transformationc-Mychexavalent chromiummiR-494

Identifiers

PMID31504995
PMCPMC6876261
OpenAlexW2970188686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.